![Samuel Barker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel Barker
Director/Board Member at
LEXICON PHARMACEUTICALS, INC.
Net worth: 466 021 $ as of 2026-05-30
Profile
Samuel L.
Barker was the founder of Clearview Projects, Inc., founded in 2001, where the title held was President & Chief Executive Officer from 2003 to 2004.
Current jobs include Independent Director at Lexicon Pharmaceuticals, Inc. since 2012, Director at Canvas Energy LLC, and Trustee at Rutgers Cancer Institute of New Jersey.
Former jobs include Chairman at Bio Green Med Solution, Inc. from 2024 to 2025, Director at AtheroGenics, Inc. from 2005 to 2009, Independent Director at Mallinckrodt Hospital Products, Inc. from 2011 to 2014, EVP-Worldwide Franchise Management & Strategy at Bristol Myers Squibb Co. from 1998 to 1999, Executive Vice President at Worldwide Franchise Systems, Inc., and EVP-Worldwide Franchise Management & Strategy at United States Pharmaceutical Group LLC in 1998.
Education includes undergraduate studies at Henderson State University (Arkansas), graduate studies at The University of Arkansas, and a doctorate from Purdue University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-02 | 213,771 ( 0.05% ) | 466 021 $ | 2026-05-30 |
Samuel Barker active positions
| Companies | Position | Start |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Director/Board Member | 2011-12-31 |
The Cancer Institute of New Jersey
 The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Operates cancer center | Director/Board Member | - |
Canvas Energy LLC
 Canvas Energy LLC Oil & Gas ProductionEnergy Minerals Provides oil and gas production & exploration services | Director/Board Member | - |
Former positions of Samuel Barker
| Companies | Position | End |
|---|---|---|
| BIO GREEN MED SOLUTION, INC. | Chairman | 2025-02-25 |
| CADENCE PHARMACEUTICALS, INC. | Director/Board Member | 2014-03-18 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Director/Board Member | 2009-03-31 |
Clearview Projects, Inc. | Chief Executive Officer | 2003-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 1998-12-31 |
Training of Samuel Barker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Worldwide Franchise Systems, Inc. | |
Henderson State University (Arkansas)
 Henderson State University (Arkansas) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Arkansas
 The University of Arkansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Cyclacel Pharmaceuticals, Inc.
 Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Clearview Projects, Inc. | |
The Cancer Institute of New Jersey
The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Operates cancer center | Health Services |
United States Pharmaceutical Group LLC
 United States Pharmaceutical Group LLC Miscellaneous Commercial ServicesCommercial Services Provides healthcare support services | Commercial Services |
Canvas Energy LLC
Canvas Energy LLC Oil & Gas ProductionEnergy Minerals Provides oil and gas production & exploration services | Energy Minerals |
- Stock Market
- Insiders
- Samuel Barker
